Organovo grants Chairman Murphy options on ~1M shares at $0.5368, vesting over 3 years

VivoSim Labs, INC.

Time-based option for 574,923 shares vests 1/3 annually over 3 years subject to continued service.
Performance-based option for 431,193 shares vests upon achieving revenue, market cap, stock price, and strategic goals.
Additional 'True-Up Options' may be granted if equity financing closes by March 31, 2025, below specified dilution thresholds.
Options granted under 2022 Equity Incentive Plan, approved by Compensation Committee on August 4, 2024.
Exercise price set at $0.5368 per share; grant date is August 5, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.